Cushing's disease: The desmopressin test as a compelling predictive marker of long-term remission after trans-sphenoidal surgery.
Sign Up to like & getrecommendations! Published in 2020 at "European journal of endocrinology"
DOI: 10.1530/eje-20-0261
Abstract: Trans-sphenoidal surgery (TSS) is the treatment of choice in Cushing's disease. However, recurrence rates are substantial and currently there are no robust predictors of late prognosis. As accumulating evidence challenge the accuracy of the traditionally… read more here.
Keywords: cushing disease; sphenoidal surgery; endocrinology; desmopressin test ... See more keywords